ABBOTT PARK, Ill., Sept. 13, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share.
This marks the 379th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2018, to shareholders of record at the close of business on Oct. 15, 2018.
Abbott has increased its dividend payout for 46 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
About Abbott: Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 99,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
Starting next week, the University of California, San Francisco, Little Manilla Rising, and El Concillo in California will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of Us Research...
Starting next week, 50Forward and Baylor College of Medicine in Houston, TX will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of Us Research Program to communities across the United...
Starting next week, Network of the National Library of Medicine and SUNY University at Buffalo in Buffalo, NY will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of Us Research Program...
Pinnacle Clinical Research, LLC ("Pinnacle") is deeply saddened by the death of Founder and Chairman Dr. Stephen Harrison. Pinnacle mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.
During an illustrious 30-year...
The International Association of Eating Disorder Professionals (iaedptm) President's Council, after the success of the 2024 Symposium, sets the standards in supporting and advancing the field of eating disorder treatment worldwide. Since its...
An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set to enhance the...
